Related Experiment Videos
Approaches for trigger-inducible viral transgene regulation in gene-based tissue engineering
Wilfried Weber1, Martin Fussenegger
1Institute of Biotechnology, Swiss Federal Institute of Technology, ETH Hoenggerberg, CH-8093 Zurich.
Current Opinion in Biotechnology
|October 7, 2004
Summary
New mammalian gene expression systems offer precise control over therapeutic transgene levels. These systems merge inducible expression with advanced viral delivery for treating complex diseases.
Area of Science:
- Biotechnology
- Molecular Biology
- Gene Therapy
Background:
- Mammalian transgene expression systems are crucial for gene therapy.
- Controlling transgene expression levels is a significant challenge in developing effective therapies.
- Existing systems lack the flexibility to fine-tune therapeutic gene output dynamically.
Purpose of the Study:
- To develop advanced, mutually compatible systems for precise control of mammalian transgene expression.
- To integrate trigger-inducible expression technology with next-generation viral transduction systems.
- To enable adaptable therapeutic cell and tissue phenotype modulation for treating complex human diseases.
Main Methods:
- Development of a portfolio of compatible transgene expression systems.
- Integration of trigger-inducible expression technology.
- Utilizing the latest generation of virus-derived transduction systems.
Main Results:
- Achieved precise adjustment of therapeutic transgene levels.
- Demonstrated compatibility between different inducible expression systems.
- Enabled dynamic control in response to various external triggers (antibiotics, hormones, etc.).
Conclusions:
- Advanced mammalian transgene expression systems offer unprecedented control over therapeutic gene delivery.
- The merger of inducible expression and viral transduction facilitates novel clinical interventions.
- These technologies hold significant promise for treating complex human diseases by shaping cell and tissue phenotypes.